F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.89 EUR 0.53% Market Closed
Market Cap: 700.1m EUR
Have any thoughts about
Fluidigm Corp?
Write Note

Fluidigm Corp
Investor Relations

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Michael Egholm Ph.D.
President, CEO & Director
No Bio Available
Mr. Hanjoon Kim
Chief Financial Officer
No Bio Available
Mr. Jonathan Mickelsen
VP & Chief Accounting Officer
No Bio Available
David Holmes
Investor Relations
No Bio Available
Mr. Sean Mackay
Chief Business Officer & Senior VP
No Bio Available
Dr. Stephen A. Williams BS, MB, Ph.D.
Chief Medical Officer
No Bio Available

Contacts

Address
CALIFORNIA
South San Francisco
2 Tower Place, Suite 2000
Contacts
+16502666000.0
www.fluidigm.com